Track Alaunos Therapeutics Inc. Common Stock — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Alaunos Therapeutics Inc. Common Stock TCRT · Stock Open Alaunos Therapeutics Inc. Common Stock in new tab

1.99 USD
Add to portfolio
EPS
-2.13
P/B
3.67
ROE
-350.30
Beta
-0.96
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
Earnings dateAug. 18, 2026
EPS-2.13
Book Value0.54
Price to Book3.67
% Insiders15.912%
Growth
Revenue Growth-0.25%
Estimates
Forward P/E-3.32
Forward EPS-0.60

DCF Valuation

Tweak assumptions to recompute fair value for Alaunos Therapeutics Inc. Common Stock (TCRT)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Alaunos Therapeutics Inc. Common Stock Logo Alaunos Therapeutics Inc. Common Stock Analysis (TCRT)

United States Health Care Official Website Stock

Is Alaunos Therapeutics Inc. Common Stock a good investment? Alaunos Therapeutics Inc. Common Stock (TCRT) is currently trading at 1.99 USD.

Earnings Schedule: Alaunos Therapeutics Inc. Common Stock is expected to release its next earnings report on Aug. 18, 2026. The market consensus estimate for Forward EPS is -0.60.

Investor FAQ

Does Alaunos Therapeutics Inc. Common Stock pay a dividend?

No, it does not currently pay a dividend.

What asset class is Alaunos Therapeutics Inc. Common Stock?

Alaunos Therapeutics Inc. Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Aug. 18, 2026. The company currently has a trailing EPS of -2.13.

Company Profile

Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs. The company also develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is based in Fort Lauderdale, Florida.

Exchange Ticker
NMS (United States) TCRT
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
Feb. 1, 2024 0.070000
July 18, 2024 0.100000
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion